Companies · Healthtech

Recuro Health, Inc.

RICHARDSON · Healthtech · refined from filed group “Other Health Care

Diligence memoA one-page analyst read on Recuro Health, Inc. — recommendation, valuation, rhythm, risks.
$44.2M
Total raised · real
2
Rounds
1.6×
Latest step-up
Top 12%
Sector rank · raised
Series B
Latest stage · inferred · Mon Aug 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

Recuro Health, Inc. looks over-valued against its niche peers and is at-risk on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the healthtech sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Over-valued
  • Modeled value is 2.06× the median modeled value of Series B Healthtech companies in 2022–2024 (98 peers) — value vs value, same stage and era.
At-risk
  • Last raise 3.9 yr ago; this sector typically re-raises about every 14 months.
  • Past due for a raise versus sector cadence — watch for distress or a bridge.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Healthtech

Recuro Health, Inc. is one of 2138 Healthtech companies tracked from RICHARDSON. By capital raised it ranks in the upper tier (ahead of 89% of sector peers), and among the largest by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
30
Investors (latest)
2021
Year incorporated
2022-08-15
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$125M$250M$375M$500MSeries A · 2021-08-23 Raised $15M (real) Modeled valuation $215M (est)$15M$215MSeries A2021Series B · 2021-08-23 Raised $17M (real) Modeled valuation $291M (est)$17M$291MSeries B2021Series B · 2022-08-15 Raised $27M (real) Modeled valuation $340M (est)$27M$340MSeries B2022+$17M+$27MCumulative $59M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Series A$14.6M · 2021
Series B$17.0M · 2021
Series B extension$27.3M · 2022

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed, Seed — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 50%.

Modeled valuation trajectory
$340.0M
Base estimate est.
$64.1M
Conservative case
$872.1M
Upside case
$151.5M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Ba $15M–$40M round). Valuation is modeled from stage benchmarks scaled by the healthtech sector profile. Directional, not a quoted figure.

Series A · modeled $214.8M · 2021-08-232021Series B · modeled $290.6M · 2021-08-23Series B · modeled $340.0M · 2022-08-152022
Model inputs · modeled:benchmark-stage-stepup-v1
18%
Dilution assumption
Implied ownership sold in the financing.
64%
Survival probability
42% low · 78% high
1.38×/yr
Annual markup
1.67×/yr upside case
3.9 yr
Elapsed time used
3.9 yr actual, capped for stale marks
healthtech
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
6 mo
Avg between rounds
$45.3M/yr
Capital velocity
4.9 yr
On record since
2021
First round
3
Rounds on file
How it compares to the market

Benchmarked against 2138 companies in Healthtech. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 9.9× above median
This company$44.2M
Sector median$4.5M
Latest round — vs other Series B rounds in sector (real $, this stage) 1.5× above median
This company$27.3M
Sector median$18.3M
Modeled value — vs sector median (estimate, all stages) 10× above median
This company$340.0M
Sector median$33.8M

Raised more than 89% of sector peers (real $). Modeled value above 91% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series B) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #11 of 98.

This companyCohort peer
$100.0M$1.0B$10.0M$100.0MCapital raised (log)Casana Care, Inc. · Series B Raised $56.4M · modeled $608.0M (est)Mendel Health Inc. · Series B Raised $52.7M · modeled $570.9M (est)Bicycle Health Inc. · Series B Raised $61.4M · modeled $492.6M (est)Brave Health, Inc. · Series B Raised $38.6M · modeled $485.7M (est)Flume Health, Inc. · Series B Raised $35.9M · modeled $446.0M (est)Healthy America, LLC · Series B Raised $31.0M · modeled $435.9M (est)Moxe Health Corp · Series B Raised $34.8M · modeled $404.2M (est)Kintsugi Mindful Wellness, Inc. · Series B Raised $25.0M · modeled $370.4M (est)Invoq Health, Inc. · Series B Raised $41.5M · modeled $362.5M (est)Folx Health, Inc. · Series B Raised $59.3M · modeled $355.7M (est)Orchard Healthcare, Inc. · Series B Raised $34.8M · modeled $338.9M (est)Recuro Health, Inc. (this company) Raised $44.2M · modeled $340.0M (est)Recuro Health, Inc.
CompanyStageRaised · realValue · estvs peer med.
Casana Care, Inc.Series B$56.4M$608.0M3.68×
Mendel Health Inc.Series B$52.7M$570.9M3.45×
Bicycle Health Inc.Series B$61.4M$492.6M2.98×
Brave Health, Inc.Series B$38.6M$485.7M2.94×
Flume Health, Inc.Series B$35.9M$446.0M2.70×
Healthy America, LLCSeries B$31.0M$435.9M2.64×
Moxe Health CorpSeries B$34.8M$404.2M2.45×
Kintsugi Mindful Wellness, Inc.Series B$25.0M$370.4M2.24×
Invoq Health, Inc.Series B$41.5M$362.5M2.19×
Folx Health, Inc.Series B$59.3M$355.7M2.15×
Recuro Health, Inc. this companySeries B$44.2M$340.0M2.06×
Orchard Healthcare, Inc.Series B$34.8M$338.9M2.05×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Series A$14.6M2021-08-23$66.6M$214.8M90%
Series B$17.0M2021-08-23$94.3M$290.6M90%
Series B$27.3M2022-08-15$151.5M$340.0M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Series A$14.6M2021-08-23
    • First recorded raise — entered as Series A.
    • 39 investors on this round.
  2. Series B$17.0M2021-08-23
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
    • 40 investors on this round.
  3. Series B$27.3M2022-08-15
    • Raised 12 mo later, in step with the ~14 mo sector norm.
    • Round 1.6× larger than the prior — scaling up.
    • 30 investors on this round.
Intelligence
2023 ~Q1
Modeled next raise · ~6mo cadence
$43.8M
Modeled next size est.range $28.5M$70.0M
1.6×
Last step-up
$45.3M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
William Paiva5 other2021-08
Michael Gorton4 other2021-08
Andrew Holm1 other2022-08
Allison Martin2022-08
Bob Zollars2022-08
Gina Fioretti2022-08
John Halsey2021-08
Kimberly Darling2022-08
Kris Engskov2021-08
Michael Brombach2022-08
Michael Moradi2021-08
Philip Fasano2022-08
Tracy Chadwell2022-08
Registry & provenance

Recuro Health, Inc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1879840
SEC CIK
2021
Incorporated
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Atropos Health IncHealthtechSeries B$44.3M$232.5Msame sector · same stage
OtoNexus Medical Technologies, Inc.HealthtechSeries B$44.5M$151.7Msame sector · same stage
Upperline Health, Inc.HealthtechSeries B$43.8M$347.7Msame sector · same stage
Bradford Health Partners, LLCHealthtechSeries B$44.8M$111.5Msame sector · same stage
XII Medical, Inc.HealthtechSeries B$45.1M$146.1Msame sector · same stage
FirstHand Health, Inc.HealthtechSeries B$42.9M$302.8Msame sector · same stage
Visana Health, Inc.HealthtechSeries B$45.6M$113.2Msame sector · same stage
Avalon Health Services, LLCHealthtechSeries B$45.8M$408.9Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Neurogami Medical, Inc.HealthtechSeries A$22.4M87%
Healthnet, IncHealthtechPre-Seed$3.7M86%
Reimagine Care, Inc.HealthtechSeries A$7.2M86%
Reperio Health, Inc.HealthtechSeries A$26.6M85%
NeuroRecovery Technologies, Inc.Software / TechSeed$103.5M85%
Rejuvatek Medical Inc.HealthtechPre-Seed$957K85%
HealthReveal, Inc.HealthtechSeries B$659.2M84%
Neurolytic Healthcare, Inc.HealthtechSeed$44.5M84%
Frequently asked
How much funding has Recuro Health, Inc. raised?
Recuro Health, Inc. has raised approximately $44.2M in disclosed capital across 2 recorded financing rounds, aggregated from public filings.
What is Recuro Health, Inc.'s estimated valuation?
Provath's modeled valuation for Recuro Health, Inc. is approximately $340.0M (modeled range $64.1M–$872.1M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Recuro Health, Inc. at?
Recuro Health, Inc.'s latest modeled financing stage is Series B. Its most recent recorded round closed around Mon Aug 15.
What does Recuro Health, Inc. do and where is it based?
Recuro Health, Inc. operates in the Healthtech sector, based in RICHARDSON.
Explore related

See where Recuro Health, Inc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Recuro Health, Inc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.